TransMedics Income Statement (2018-2026) | TMDX

Income Statement Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter)
8.17M5.41M8.54M15.88M20.52M25.68M31.38M41.55M52.47M66.43M81.17M96.85M114.31M108.76M121.62M143.54M157.37M143.82M160.76M173.93M
Cost of Revenue (Quarter)
2.58M1.60M2.68M3.78M6.17M7.57M10.67M12.79M15.72M25.77M33.25M36.89M45.04M47.92M49.61M55.31M60.78M59.25M67.35M72.77M
Gross Profit (Quarter)
5.59M3.77M6.99M12.10M14.35M18.11M20.70M28.77M36.74M40.66M47.92M59.96M69.26M60.84M72.01M88.23M96.59M84.58M93.41M101.16M
Operating items
Research & Development (Quarter)
6.29M5.16M6.31M7.53M6.71M6.81M5.76M5.87M8.29M11.13M10.76M11.38M13.86M14.27M16.46M17.16M15.93M15.26M20.70M24.88M
Selling, General & Administrative (Quarter)
9.16M10.34M12.00M13.94M17.38M16.85M21.73M24.98M29.36M30.65M34.56M36.16M42.90M42.66M46.91M43.62M44.09M46.02M51.44M62.98M
Other Operating Expenses (Quarter)
27.21M
Operating Expenses (Quarter)
15.46M15.50M18.31M21.47M24.09M23.66M27.48M30.86M37.65M69.00M45.32M47.54M56.75M56.92M63.37M60.78M60.02M61.27M72.14M87.86M
Operating Income (Quarter)
-9.87M-11.72M-11.33M-9.37M-9.74M-5.54M-6.78M-2.09M-0.91M-28.34M2.60M12.42M12.51M3.92M8.64M27.44M36.57M23.30M-64.73M13.30M
EBIT (Quarter)
-9.87M-11.72M-11.33M-9.37M-9.74M-5.54M-6.78M-2.09M-0.91M-28.34M2.60M12.42M12.51M3.92M8.64M27.44M36.57M23.30M-64.73M13.30M
Non-operating items
Other Non Operating Income (Quarter)
0.17M-0.25M-0.34M-0.23M-0.78M-1.08M1.08M0.56M2.43M5.00M4.87M3.57M3.27M3.94M1.92M2.69M3.09M3.22M3.71M2.36M
Non Operating Income (Quarter)
0.17M-1.23M-1.32M-0.23M-0.78M-1.86M0.08M-0.54M-0.07M1.41M1.26M-0.03M-0.35M0.32M-1.66M-0.77M-0.39M-0.27M0.36M-4.81M
Net income details
EBT (Quarter)
-10.66M-12.95M31.67M-10.56M-11.50M-7.41M-6.70M-2.62M-0.98M-26.93M30.90M12.39M12.15M4.25M-28.33M26.68M36.18M23.03M-84.72M8.48M
Tax Provisions (Quarter)
0.01M0.01M0.02M0.01M0.02M0.02M0.02M0.01M0.02M-1.51M1.50M0.20M-0.04M0.03M-0.08M0.99M1.30M-1.29M-103.30M1.17M
Profit After Tax (Quarter)
-10.67M-12.96M-12.67M-10.56M-11.52M-7.43M-6.72M-2.64M-1.00M-25.42M4.03M12.20M12.19M4.22M6.86M25.68M34.91M24.32M105.38M7.32M
Income from Continuing Operations (Quarter)
-10.67M-12.96M31.65M-10.56M-11.52M-7.43M-6.72M-2.64M-1.00M-25.42M29.40M12.20M12.19M4.22M-28.25M25.68M34.88M24.32M18.58M7.32M
Consolidated Net Income (Quarter)
-10.67M-12.96M31.65M-10.56M-11.52M-7.43M-6.72M-2.64M-1.00M-25.42M29.40M12.20M12.19M4.22M-28.25M25.68M34.88M24.32M18.58M7.32M
Income towards Parent Company (Quarter)
-10.67M-12.96M31.65M-10.56M-11.52M-7.43M-6.72M-2.64M-1.00M-25.42M29.40M12.20M12.19M4.22M-28.25M25.68M34.88M24.32M18.58M7.32M
Net Income towards Common Stockholders (Quarter)
-10.67M-12.96M31.65M-10.56M-11.52M-7.43M-6.72M-2.64M-1.00M-25.42M29.40M12.20M12.19M4.22M-28.25M28.03M34.88M24.32M18.58M7.32M
Additional items
EPS (Basic) (Quarter)
-0.39-0.47-0.46-0.38-0.41-0.25-0.20-0.08-0.03-0.780.120.370.370.130.210.761.030.713.100.21
EPS (Weighted Average and Diluted) (Quarter)
-0.39-0.47-0.46-0.38-0.41-0.25-0.20-0.08-0.03-0.780.120.350.350.120.200.700.920.662.590.20
Shares Outstanding (Weighted Average) (Quarter)
27.62M27.70M27.62M27.95M27.97M28.73M29.56M32.26M32.40M32.47M32.52M32.76M32.94M33.11M33.23M33.72M33.82M34.11M33.99M34.38M
Shares Outstanding (Diluted Average) (Quarter)
27.50M27.70M27.62M27.95M27.97M28.73M29.56M32.26M32.55M32.47M32.52M34.68M34.98M35.68M
EBITDA (Quarter)
-9.87M-11.72M-11.33M-9.37M-9.74M-5.54M-6.78M-2.09M-0.91M-28.34M2.60M12.42M12.51M3.92M8.64M27.44M36.57M23.30M-64.73M13.30M
Interest Expenses (Quarter)
0.96M0.98M0.98M0.96M0.97M0.79M1.01M1.09M2.50M3.59M3.60M3.60M3.62M3.62M3.57M3.46M3.48M3.49M3.35M7.17M
Tax Rate (Quarter)
-0.06%-0.07%0.05%-0.06%-0.19%-0.26%-0.28%-0.42%-2.14%5.60%4.85%1.58%-0.34%0.68%0.30%3.73%3.59%-5.59%121.93%13.79%